Alaunos Therapeutics to effect 1-for-10 reverse stock split effective July 17, 2024

Alaunos Therapeutics, Inc.

Reverse split at 1-for-10 ratio; effective 5:00 p.m. Eastern on July 17, 2024.
Stock will trade split-adjusted on Nasdaq under symbol 'TCRT' starting July 18, 2024 with new CUSIP 98973P309.
Stockholder approval obtained at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
Equiniti Trust Company appointed as exchange agent to handle share conversion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.